Primary Cells Market Overview

Primary human cells are necessary for some medical purposes like researches. Market Research Future (MRFR) has published a research report about the global primary cells market that has predicted significant growth with 10.40% CAGR (Compound Annual Growth Rate) for this market. The key factors that drive this market are growing cancer research, increasing demand for monoclonal antibodies, rapid growth in biotechnology and biopharmaceutical industries, rising healthcare expenditure, and various other advantages. However, factors that can obstruct the growth of this market include the high cost of advanced primary cells and risk of contamination.

The rapid expansion of pharmaceutical sector and the growth of biotechnology are expected to be significant factors that can drive the primary cells market. The surging prevalence of cancer and the on-going research on the diseases is predicted to enhance the requirement for tissue samples that can augment the industry in the forecast period. The animal primary cells and human primary cells aid in producing vaccines for diseases and aid in generating vivo models respectively that may propel the demand and actuate the market. In addition, the increasing preference for primary cells to develop new drugs can strengthen the Primary Cells Market considerably during the assessment period.

Increased research activities focused on biopharmaceutical discovery and biotechnology, increased investment in cancer research, growing demand for monoclonal antibodies and higher healthcare expenditure are some of the key factor influencing the global primary cells market. Primary human cells are preferred over cell lines which also remains a positive factor. Unlike endothelial cell lines, endothelial cells retain most functional markers. Primary cells being a novel technology is relatively more expensive. At the same time, issue of cell contamination is yet to be effectively addressed.

Primary Cells Market Segmentation

• The MRFR report provides an inclusive segmental analysis of the global primary cells market based on end user, type, and source. 

• By source, the global primary cells market is segmented into muscle and skeletal cells, lung cells, liver cells, gastrointestinal cells, skin cells, and hematopoietic cells. 

• By type, the global primary cells market is segmented into animal primary cells and human primary cells. 

• By end user, the global primary cells market is segmented into research institutes and pharmaceutical & biotechnology companies. 

Primary Cells Market Regional Analysis

Based on region, the market has been segmented into Europe, Americas, the Middle East and Africa (MEA), and Asia Pacific (APAC). The Americas cells market cover both South America and North America. The Europe primary cells market covers Eastern Europe and Western Europe. Key countries covered in the Asia Pacific primary cells market include China, South Korea, Japan, Australia, and India. In terms of revenue, North America and South America collectively dominate the global primary cells market. Some of the key factors supporting the growth of the market in Americas include strong government backing for R&D, easy access to latest medical technologies and increased prevalence of cancer. Data released by National Cancer Institute revealed that nearly 1,685,210 new cases of cancer were recorded in the US in 2016.

Europe in holds the second spot in terms of value. Healthcare remains a major area of focus for the EU. Over the years, several policies have been launched to improve health care services in the region. Advanced countries in Europe present attractive growth opportunities for market players. In 2016, the gross domestic expenditure on R&D activities was more than Euro 33 Bn as per the office for National Statistics.

APAC is viewed as an emerging market for primary cells. The healthcare sector in APAC is witnessing tremendous growth, which is translating into opportunities for market players. Rising number of cancer cases, introduction favourable policies and pharmaceutical outsourcing are some of the factors supporting the market growth in APAC. Spending on medical science R&D institutes have surged in countries such as China and India, which is paving the way for the market to growth. The market in MEA is also expected to grow at a healthy pace but from a lower base. Many of the countries in MEA face issues such as underdeveloped healthcare infrastructure, limited access to services, etc.

Primary Cells Market Players

• AllCells (US)
• ZenBio Inc. (Research Triangle Park NC)
• PromoCell (UK)
• Thermo Fisher Scientific Inc. (US)
• Cell Biologics Inc. (Chicago)
• STEMCELL Technologies Inc. (Canada)
• Merck KGaA (Germany)
• American Type Culture Collection (ATCC)
• AG (Switzerland)
• Others

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/primary-cells-market-6296

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com